Dow Down 0.22% Nasdaq Up 0.14%

Arrowhead Research Corp. (ARWR)

-NasdaqGS
12.80 Up 0.08(0.63%) Aug 22, 4:00PM EDT
|After Hours : 12.80 0.00 (0.00%) Aug 22, 7:35PM EDT
Prev Close:12.72
Open:12.70
Bid:12.71 x 2000
Ask:12.83 x 900
1y Target Est:33.50
Beta:2.95
Next Earnings Date:N/A
Day's Range:12.17 - 12.99
52wk Range:4.08 - 27.63
Volume:3,951,355
Avg Vol (3m):2,681,200
Market Cap:677.22M
P/E (ttm):N/A
EPS (ttm):-1.20
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ARWR

Comparison

Symbol% ChgMkt Cap
ARWRUp 0.63%677.22M
APNTDown 7.38%11.73M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):3,845.68
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Sep-14) :-1.04
Quarterly EPS Est (Sep-14) :-0.24
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):-1.67

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Arrowhead Research Corporation, a biopharmaceutical company, develops targeted RNAi therapeutics in the United States. The company’s product candidate comprise ARC-520, an RNAi-based therapeutic that has completed a Phase 1 clinical trial for... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback